SEC Form 4 · accession 0001144204-15-021414
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Strobeck
Director
Period of report
Apr 2, 2015
Accepted (ET)
Apr 6, 2015 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,045,560 | D | ||
| Common StockF1 | holding | — | — | — | 22,000 | I | Through Birchview Fund, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $22.92 | Apr 2, 2015 | A | 7,658 | A | — | Apr 2, 2025 | Common Stock | 7,658 | 66,756 | D |
| Stock Option (right to buy) | $6.48 | holding | — | — | — | Apr 3, 2014 | Apr 3, 2023 | Common Stock | 44,670 | 44,670 | D |
| Stock Option (right to buy) | $21.31 | holding | — | — | — | Apr 3, 2015 | Apr 3, 2024 | Common Stock | 14,428 | 59,098 | D |
Explanation of responses
- F1The reporting person has sole voting and dispositive power with respect to the shares held by Birchview Fund, LLC in his capacity as the CEO of such entity. The reporting person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2The stock option vests in 12 equal monthly installments, with the first installment vesting on May 2, 2015.